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1. Introduction 
Deep venous thrombosis (DVT) is an illness of clinical interest, due to the associated 
morbidity and mortality and its social and health care consequences. The etiology in young 
patients has shown it frequently associated with congenital coagulation abnormalities and 
acquired/inherited risk factors (table I) (a,b). 
 
Inherited 
Common 
G169A mutation in the factor V gene (factor V Leiden) 
G20219A mutation in the protrombin (factor II) gene 
Homozygous C677T mutation in the methylenetetrahydrofolate reductase gene 
Rare 
Antitrombin deficiency 
Protein C deficiency 
Protein S deficiency  
Very rare 
Dysfibrinogenemia 
Homozygous homocystinuria 
Probably inherited 
Increased levels of factor VII, IX, XI or fibrinogen 
Acquired 
Surgery and trauma 
Prolonged immobilization 
Older age 
Cancer 
Myeloproliferative disorders 
Previous thrombosis 
Pregnancy and the puerperium 
Use of contraceptives or hormone-replacement therapy 
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Resistence to activated protein C (not due alterations in the factor V gene 
Antiphospholipid antibodies) 
Mild to moderate hyperomocysteinemia 
Table 1. inherited and acquired risk factors for DVT. 
However, recent radiological advances derived from multislice computerized tomography 
(CT) and magnetic resonance imaging (MRI) have identified vena cava malformations as a 
new etiologic factor to be considered.(c-g) 
The objectives of the present chapter are to describe the embryogenesis and the spectrum of 
congenital anomalies of the inferior vena cava (IVC) as a risk factor in DVT in young 
patients. Anomalies of the inferior vena cava (IVC) and its tributaries have been known to 
anatomists since 1793, when Abernethy(h) described a congenital meso-caval shunt and 
azygos continuation of the IVC in a 10-month-old infant with polysplenia and dextrocardia. 
Since the development of cross-sectional imaging, congenital anomalies of the IVC and its 
tributaries have become more frequently encountered in asymptomatic patients(c). The 
imaging study with CT and MRI of the abdominal vein structures require a specific 
thecnique of acquisition in relation with contrast medium injection. During the usual 
vascular study, that are acquired in arterial phase, the visualization of veins is not adequate 
for the recognition of the vein system. This may are usually readily identified on CT and 
magnetic resonance (MR) imaging scans of the abdomen and pelvis obtained with 
intravenously administered contrast medium. In addition, with helical acquisition, the 
venous structures may be imaged during the arterial phase, when little or no contrast 
material is present in the veins. Therefore, in these cases the diagnostic request is essential 
for correct interpretation of vein vasculature and to avoid erroneous diagnosis 
(retroperitoneal and mediastinal masses or adenopathy) and to alert the surgeon and 
angiographer about the characteristics of vascular anatomy. 
1.1 The embryogenesis of the IVC 
The embryogenesis and the anatomic variations of the IVC become more clear with the 
development of the CT and magnetic resonance (MR) imaging in clinical practice. In the past 
Phillips(i) has published a comprehensive review of the embryogenesis of the IVC. In brief, 
the infrahepatic IVC develops between the 6th and 8th weeks of embryonic life as a 
composite structure formed from the continuous appearance and regression of three paired 
embryonic veins. In order of appearance, they are the posterior cardinal, the subcardinal, 
and the supracardinal veins (Fig 1).  
Under ordinary circumstances, the prerenal division is formed from union of the hepatic 
segment (green area), a vitelline vein derivative, and the right subcardinal vein (magenta 
area). The renal segment is formed from the suprasubcardinal anastomosis (yellow area) 
and the postsubcardinal anastomosis (light violet area). The infrarenal segment derives from 
the right supracardinal vein (goldenrod area). The posterior cardinal veins (dark violet area) 
form the iliac veins (Adapted and reprinted, with permission, from reference d). Initially, all 
blood return from the body wall caudal to the heart proceeds through the posterior cardinal 
veins (dark violet in Fig 1). Blood return from the viscera is conveyed by the vitelline veins 
(green in Fig 1), which drain the yolk sac. Subsequently, the subcardinal veins (magenta in 
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Fig 1) develop ventromedial to the posterior cardinal veins and ventrolateral to the aorta. 
The intersubcardinal anastomosis forms between the paired subcardinal veins, anterior to 
the aorta, and caudal to the superior mesenteric artery. 
 
Fig. 1. Conceptual framework for development of the IVC. Composite schematic shows the 
relative positions and interrelationships of the three paired embryonic vessels that 
contribute to development of the IVC. The pictured veins are not all present simultaneously. 
card= cardinal, post= posterior, SMA= superior mesenteric artery, v= vein, 1= 
intersubcardinal anastomosis, 2 = intersupracardinal anastomosis.  
Anastomosis between the posterior cardinal and subcardinal veins (light violet in Fig 1) 
develop on each side at approximately the level of the intersubcardinal anastomosis. At the 
same time, union occurs between the right subcardinal vein and the hepatic segment of the 
IVC, which forms from the vitelline vein. As the cranial portions of the posterior cardinal 
veins begin to atrophy, blood return from the lower extremities is shunted through the 
postsubcardinal anastomosis, then through the subcardinal-hepatic anastomosis to the 
hepatic segment of the IVC. This process establishes the pre-renal division of the IVC. The 
next major development is the appearance of the paired supra-cardinal veins (goldenrod in 
Fig 1), which lie dorso-medial to the posterior cardinal veins and dorso-lateral to the aorta. 
Initially, multiple anastomosis form between the posterior and supracardinal veins. On each 
side, a suprasubcardinal anastomosis (yellow in Fig 1) develops from union of the 
postsupracardinal and the postsubcardinal anastomosis. In addition, intersupracardinal 
anastomosis develop dorsal to the aorta. The supracardinal veins then separate into cranial 
(azygos) and caudal (lumbar) ends. Meanwhile, inferiorly, anastomosis develop between the 
two posterior cardinal veins and between the posterior and lumbar supracardinal veins. 
With further atrophy of the posterior cardinal veins, blood return from the lower extremities 
is shunted through the supracardinal system to the suprasubcardinal anastomosis, then to 
the pre-renal division of the IVC. In addition, blood return from the left side of the body is 
shunted to the right across the intersupracardinal and interpostcardinal anastomosis. 
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Finally, the left supracardinal vein is one of the last veins to disappear, although Huntington 
and McLure(j) state that the vessel does not so much atrophy as become incorporated into 
the right supracardinal vein by coalescence of the multiple anastomosis. In summary, the 
normal IVC is composed of four segments: hepatic, suprarenal, renal, and infrarenal. The 
hepatic segment is derived from the vitelline vein. The right subcardinal vein develops into 
the suprarenal segment by formation of the subcardinal-hepatic anastomosis. The renal 
segment develops from the right suprasubcardinal and postsubcardinal anastomosis. It is 
generally accepted that the infra-renal segment derives from the right supracardinal vein, 
although this idea is somewhat controversial(i). In the thoracic region, the supracardinal 
veins give rise to the azygos and hemiazygos veins. In the abdomen, the postcardinal veins 
are progressively replaced by the subcardinal and supracardinal veins but persist in the 
pelvis as the common iliac veins. 
2. Variations in IVC anatomy 
In a study of the development of the IVC in the domestic cat (Felis domestica), Huntington 
and McLure(j) proposed a classification system for IVC anomalies based on abnormal 
regression or abnormal persistence of various embryonic veins. These investigators 
suggested that there could be up to 14 theoretical variations in the anatomy of the infra-
renal IVC. They noted that 11 of the 14 variants had been observed in the domestic cat or in 
humans. In addition, these authors observed that other anomalies seen in humans, such as 
abnormal development of the pre-renal division of the IVC and persistence of the renal 
collar in the adult, could be explained on a similar basis.  
2.1 Left IVC 
A left IVC results from regression of the right supra-cardinal vein with persistence of the left 
supra-cardinal vein. The prevalence is 0.2%–0.5%(i). Typically, the left IVC joins the left renal 
vein, which crosses anterior to the aorta in the normal fashion, uniting with the right renal 
vein to form a normal right-sided prerenal IVC (Fig 2). 
2.2 Double IVC 
Duplication of the IVC results from persistence of both supracardinal veins. The prevalence 
is 0.2%–3%(i). The left IVC typically ends at the left renal vein, which crosses anterior to the 
aorta in the normal fashion to join the right IVC (Fig 3). 
2.3 Azygos continuation of the IVC 
Azygos continuation of the IVC has also been termed absence of the hepatic segment of the 
IVC with azygos continuation(k). The embryonic event is theorized to be failure to form the 
right sub-cardinal–hepatic anastomosis, with resulting atrophy of the right sub-cardinal 
vein. Consequently, blood is shunted from the supra-sub-cardinal anastomosis through the 
retro-crural azygos vein, which is partially derived from the thoracic segment of the right 
supra-cardinal vein. The prevalence is 0.6%(k). The renal portion of the IVC receives blood 
return from both kidneys and passes posterior to the diaphragmatic crura to enter the 
thorax as the azygos vein (Fig 4).  
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(a) 
 
Fig. 2. Partial malrotation and left IVC in a 49-year-old man. (a) Schematic shows a left IVC 
terminating at the left renal vein. (b-e) CT scans presented from caudal to cranial show the 
anomaly. (b) Note the left IVC (arrow) inferior to the renal veins. (c) The left IVC joins the 
left renal vein (arrow). (d) The left renal vein (arrow) crosses anterior to the aorta in the 
normal fashion. (e) A normal right-sided prerenal IVC is formed from the confluence of the 
left (straight arrow) and right (curved arrow) renal veins. Note the increased attenuation of 
the right renal vein relative to that of the left due to absence of dilution from relatively 
unenhanced lower-extremity venous return. The major clinical significance of this anomaly 
is the potential for misdiagnosis as left-sided paraaortic adenopathy(k). 
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(a) 
 
Fig. 3. Double IVC in a 53-year-old woman with lymphoma. (a) Schematic shows left and 
right infrarenal IVCs. The left IVC terminates at the left renal vein. (b) CT scan obtained 
inferior to the renal veins shows left (straight arrow) and right (curved arrow) IVCs. (c-e) CT 
scans show the left IVC ending at the confluence with the left renal vein (arrow in c), which 
crosses anterior to the aorta in the normal fashion (arrow in d) to join a normal pre-renal 
IVC (arrow in e). There may be morphological variation and asymmetry of the left and right 
veins. Double IVC should be suspected in cases of recurrent pulmonary embolism following 
placement of an IVC filter(i).  
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(a) 
 
Fig. 4. CT images of azygos continuation of the IVC in a 48-year-old man. (a) Schematic 
shows lack of contiguity between the pre-renal segment of the IVC (arrow) and the hepatic 
segment. The vessel parallel to the aorta under the crus is the azygos vein. (b, c) CT scans 
obtained at the level of the diaphragmatic crus (b) and the level of the azygos vein arch (c) 
show the enlarged azygos vein (straight arrow) draining into the superior vena cava (curved 
arrow in c). 
The azygos vein joins the superior vena cava at the normal location in the right para-tracheal 
space. The hepatic segment (often termed the post-hepatic segment) is ordinarily not truly 
absent; rather, it drains directly into the right atrium. Since the post-sub-cardinal 
anastomosis does not contribute to formation of the IVC, each gonadal vein drains to the 
ipsi-lateral renal vein(j). Formerly thought to be predominantly associated with severe 
congenital heart disease and a-splenia or poly-splenia syndromes, azygos continuation of 
the IVC has become increasingly recognized in otherwise asymptomatic patients since the 
advent of cross-sectional imaging. It is important to recognize the enlarged azygos vein at 
the confluence with the superior vena cava and in the retrocrural space to avoid 
misdiagnosis as a right-sided para-tracheal mass or retro-crural adenopathy(k,l). Preoperative 
knowledge of the anatomy may be important in planning cardiopulmonary bypass and to 
avoid difficulties in catheterizing the heart(m). 
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(a) 
 
Fig. 5. Circumaortic left renal vein in a 73-year-old woman. (a) Schematic shows two left 
renal veins, with the inferior vein crossing posterior to the aorta. (b-e) Contiguous 5-mm-
thick CT sections presented from cranial to caudal show the anomaly. (b) The superior left 
renal vein (arrow) crosses anterior to the aorta. (c-e) The inferior vein (curved arrow) 
descends approximately 2 cm and receives the left gonadal vein (straight arrow in d) before 
crossing posterior to the aorta. The major clinical significance is in preoperative planning 
prior to nephrectomy and in renal vein catheterization for venous sampling. Misdiagnosis as 
retroperitoneal adenopathy should be avoided. 
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2.4 Circum-aortic left renal vein 
A circum-aortic left renal vein results from persistence of the dorsal limb of the embryonic 
left renal vein and of the dorsal arch of the renal collar (inter-supra-cardinal anastomosis). 
The prevalence may be as high as 8.7%(i). Two left renal veins are present. The superior renal 
vein receives the left adrenal vein and crosses the aorta anteriorly. The inferior renal vein 
receives the left gonadal vein and crosses posterior to the aorta approximately 1–2 cm 
inferior to the normal anterior vein (Fig 5).  
2.5 Retro-aortic left renal vein 
As with circum-aortic left renal vein, a retro-aortic left renal vein results from persistence of 
the dorsal arch of the renal collar. However, in this variation the ventral arch (inter-
subcardinal anastomosis) regresses so that a single renal vein passes posterior to the aorta 
(Fig 6). The prevalence is 2.1%(i). The clinical significance is preoperative recognition of the 
anomaly. 
(a) 
 
Fig. 6. Retroaortic left renal vein in a 27-year-old man. (a) Schematic shows a single left renal 
vein, which crosses posterior to the aorta. (b, c) CT scans show the left renal vein (arrow) 
descending to cross posterior to the aorta. 
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(a) 
 
Fig. 7. Spinal dysraphism and double IVC with hemiazygos continuation in a 2-year-old 
boy. (a) Schematic shows failed development of the right pre-renal IVC and hemi-azygos 
continuation of the left IVC. (b-e) MR images presented from caudal to cranial show the 
anomaly. (b) Note the right (straight arrow) and left (curved arrow) IVCs. (c) The right renal 
vein (arrowhead) descends to receive the right IVC and crosses posterior to the aorta 
(arrow) to join the left IVC. (d) The left IVC continues cephalad left of the aorta under the 
diaphragmatic crus as the hemi-azygos vein (arrow). (e) In the thorax, the hemi-azygos vein 
(straight arrow) crosses posterior to the aorta (arrowhead) to join a rudimentary azygos vein 
(curved arrow) approximately 1-2 cm below the carina. 
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2.6 Double IVC with retro-aortic right renal vein and hemi-azygos continuation of the 
IVC 
More than one anomaly can coexist in a patient. In the case of a double IVC with a retro-aortic 
right renal vein and hemi-azygos continuation of the IVC, the embryologic basis is persistence 
of the left lumbar and thoracic supra-cardinal vein and the left supra-sub-cardinal 
anastomosis, together with failure of formation of the right sub-cardinal–hepatic anastomosis. 
In addition, the right renal vein and right IVC meet and cross posterior to the aorta to join the 
left IVC and continue cephalad as the hemi-azygos vein (Fig 7). Thus, there is also persistence 
of the dorsal limb of the renal collar and regression of the ventral limb. In the thorax, the hemi-
azygos vein crosses posterior to the aorta at approximately T8 or T9 to join the rudimentary 
azygos vein. Alternate collateral pathways for the hemi-azygos vein include cephalad 
continuation to join the coronary vein of the heart via a persistent left superior vena cava and 
an accessory hemi-azygos continuation to the left brachio-cephalic vein(n). 
2.7 Double IVC with retro-aortic left renal vein and hemiazygos continuation of the 
IVCA 
Double IVC with a retro-aortic left renal vein and azygos continuation of the IVC is an 
interesting combination. It results from persistence of the left supracardinal vein and the 
dorsal limb of the renal collar with regression of the ventral limb. In addition, the sub-
cardinal-hepatic anastomosis fails to form (Fig 7). A recent study demonstrated that azygos 
continuation of the IVC can be predicted with ultrasonography by identifying the right renal 
artery crossing abnormally anterior to the IVC (15). 
2.8 Circum-caval ureter 
A circum-caval ureter is also termed a retro-caval ureter. The right supra-cardinal system 
fails to develop, whereas the right posterior cardinal vein persists. The anomaly always 
occurs on the right side. The proximal ureter courses posterior to the IVC, then emerges to 
the right of the aorta, coming to lie anterior to the right iliac vessels (Fig 8). Patients with this 
anomaly may develop partial right ureteral obstruction or recurrent urinary tract infections. 
Therapeutic options include surgical relocation of the ureter anterior to the cava(i). 
2.9 Absent Infra-renal IVC with preservation of the supra-renal segment 
Several reports have described absence of the entire IVC (o–r) or absence of the infra-renal 
IVC with preservation of the supra-renal segment (Fig 9) (s,t). Absence of the entire 
posthepatic IVC suggests that all three paired venous systems failed to develop properly.  
Absence of the infrarenal IVC implies failure of development of the posterior cardinal and 
supracardinal veins. Since it is difficult to identify a single embryonic event that can lead to 
either of these scenarios, there is controversy as to whether these conditions are true 
embryonic anomalies or the result of perinatal IVC thrombosis (p,s,t).  
3. Implications for treatment of DVT and prevention of recurrences 
The therapy of acute DVT in this kind of patients is similar of the currently recommended 
strategies and includes un-fractioned heparin, low-molecular weight heparin, fondaparinux  
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(a) 
 
Fig. 8. Circumcaval ureter in a 65-year-old man. (a) Schematic shows the right ureter 
encircling the IVC. (b-d) CT scans presented from cranial to caudal show the anomaly. (b) 
The right ureter (arrow) is positioned posterior to the IVC. (c) The ureter (arrow) then 
courses to the left of the IVC. (d) Finally, the ureter (arrow) crosses anterior to the IVC. 
(Courtesy of Akira Kawashima, MD, Lyndon B. Johnson General Hospital, Houston, Tex.) 
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(a) 
 
Fig. 9. Absent infra-renal IVC. (a) Schematic shows absence of the IVC below the renal veins. 
Collateral flow from the lower extremities reaches the azygos vein via para-vertebral 
collateral veins. (b) CT scan obtained inferior to the aortic bifurcation shows absence of the 
common iliac veins. Enlarged ascending lumbar veins are present (black arrow). Note the 
iliac arteries (white arrow). (c) CT scan obtained inferior to the kidneys shows absence of the 
IVC (white arrow). Enlarged ascending lumbar veins are present (black arrow). (d) CT scan 
obtained at the level of the renal veins shows a normal pre-renal IVC formed at the 
confluence of the renal veins (arrow). (e) CT scan obtained at the level of the pre-renal IVC 
(white arrow) shows prominent para-vertebral collateral veins (black arrow), which lead to 
a prominent azygos vein (arrowhead). (f) Coronal T1-weighted MR image shows the 
enlarged ascending lumbar veins (arrow). (g) Lateral maximum-intensity projection 
reconstruction of two-dimensional time-of-flight MR images shows formation of enlarged 
ascending lumbar veins at the confluence of the internal and external iliac veins (solid 
straight arrow). Note the anastomosis between the ascending lumbar veins and the azygos 
vein (open straight arrow) via prominent anterior para-vertebral veins (white curved 
arrow). Also note the pre-renal IVC (black arrowhead) posterior to the portal vein (black 
curved arrow), as well as prominent anterior abdominal wall collateral veins (white 
arrowheads). (Figs 10b, 10c, and 10g reprinted, with permission, from references). 
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and vitamin-K antagonists(u). The diagnosis of anomalies in the inferior vena cava influences 
the strategy for prevention the pulmonary embolism and long them maintenance treatment. 
The use of mechanical device as caval filter is clearly limited by the anomalous anatomy of 
the inferior vena cava and, generally, is-not indicated. On the other hand the use of oral anti-
coagulant (commonly warfarin) should be adjusted to maintain a target international 
normalized ratio of 2.5 (range 2-3) and extended indefinitely in absence of main contra-
indications(d). 
At present the introduction of new drugs as the factor Xa antagonists (rivarixaban, 
apixaban, edoxaban, ect) and the direct thrombin inhibitors as dabigatran etexilate could 
improve the therapeutic options. The promising results of the recent clinical studies in terms 
of efficacy and safety, suggest that these new drugs may allow a reduction of the length of 
hospital stay after an acute DVT, and a better adherence to guidelines in the long term 
treatment. The principal advantages of these drugs are the absence of the need of a routine 
coagulation monitoring and a therapeutic activity not influenced by dietary regimen and by 
drugs as NSADIs and statins(u). Potential limitations are the lack of specific antidotes 
(however the hal-life of these drugs is relative short) and the absence of a simple assay for 
quantification of activity or plasma level.  
In conclusion these interesting pharmacological characteristics could improve the benefit-
risk balance of long-term anti-coagulant therapy and the overall clinical outcome.  
4. Conclusions 
The complexity of the ontogeny of the IVC, with numerous anastomosis formed between the 
three primitive paired veins, can lead to a wide array of variations in the basic plan of 
venous return from the abdomen and lower extremity. Some of these anomalies have 
significant clinical implications. Although vascular structures can usually be readily 
identified on contrast-enhanced CT scans, identification of unusual venous arrangements 
may be difficult in those cases in which intravenous contrast material is contraindicated. In 
such patients, MR imaging may be used to distinguish aberrant vessels from masses by 
demonstrating flow voids or flow-related enhancement. The echo-scanning may suggest the 
presence of venous anomalies but usually it insufficient for a detailed diagnosis. A 
knowledge of IVC and renal vein anomalies is essential to avoid diagnostic pitfalls. 
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